News blog

Hepatitis C drug nears approval

A highly anticipated new drug for treating hepatitis C has sailed through its first phase III clinical trials, according to two papers published today in the New England Journal of Medicine. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE